Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1050
-0.0050 (-4.55%)
Jul 20, 2026, 5:45 PM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 14.33 million as of July 21, 2026. Its market cap has decreased by -44.71% in one year.
Market Cap
14.33M
Enterprise Value
19.64M
Revenue
2.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
ChartMarket Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 14.33M, a decrease of -77.53%. That is a compound annual growth rate of -17.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 14.33M | -18.84% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 28.79M |
| Lobe Sciences | 28.41M |
| Sharp Therapeutics | 27.37M |
| Alzai Health | 25.02M |
| Devonian Health Group | 19.49M |
| Pharmala Biotech Holdings | 16.33M |
| Hemostemix | 12.86M |
| Britannia Life Sciences | 11.36M |